Reducing Nicotine in Cigarettes: The Impact on Public Health
The FDA is proposing a cap on nicotine in cigarettes that would reduce the amount by 95%, which could...
Category: Policy
The FDA is proposing a cap on nicotine in cigarettes that would reduce the amount by 95%, which could...
A series published in the AACR journal Clinical Cancer Research shared key considerations for improving dosage optimization in oncology.
From July 1 to September 30, 2025, the FDA issued eight new oncology approvals, expanding treatment options for patients...
Richard and Michelle Schlueter attended the Rally for Medical Research to advocate for NIH funding after budget cuts delayed...
A workshop hosted by AACR and FDA explored novel clinical trial oncology endpoints and considerations for their validation and...
In the second quarter of 2025, the FDA issued 13 new oncology approvals, including options for rare cancers, head...
A congressional forum hosted by Senators Tammy Baldwin and Peter Welch examined how NIH funding cuts could impact cancer...
In the first quarter of 2025, the FDA issued 13 approvals for oncology treatments, covering nine types of cancer...
Natalie Snider-Hoy, a PhD candidate at Wayne State University, attended AACR Early-career Hill Day 2025 to advocate for sustained...
In the final three months of 2024, the FDA issued 15 approvals in oncology, including several therapies that are...